Literature DB >> 23995180

Review: the role of inflammation in depression.

Amisha Patel1.   

Abstract

The role of inflammation in major depressive disorder (MDD) has been of growing interest over the past two decades and evidence suggests it plays a role in depression. Evidence linking inflammation to MDD comes from three different observations (a) elevated levels of inflammatory markers in patients with MDD, even in the absence of illness, (b) co-occurrence of MDD with inflammatory illnesses and (c) increased risk of MDD with cytokine treatment. Cytokines have been found to influence almost every pathway involved in the pathogenesis of depression including alterations to the expression of neurotransmitters, neuroendocrine function, synaptic plasticity and basal ganglia. The similarities between cytokine-induced sickness behaviour and MDD further support a role of inflammation in depression as well as the anti-inflammatory effects of successful antidepressant treatment. This account describes the inflammatory mechanisms thought to be involved in MDD and the evidence for this.

Entities:  

Mesh:

Year:  2013        PMID: 23995180

Source DB:  PubMed          Journal:  Psychiatr Danub        ISSN: 0353-5053            Impact factor:   1.063


  30 in total

Review 1.  The cellular and molecular basis of major depressive disorder: towards a unified model for understanding clinical depression.

Authors:  Eleni Pitsillou; Sarah M Bresnehan; Evan A Kagarakis; Stevano J Wijoyo; Julia Liang; Andrew Hung; Tom C Karagiannis
Journal:  Mol Biol Rep       Date:  2019-10-14       Impact factor: 2.316

2.  Gentiopicroside abrogates lipopolysaccharide-induced depressive-like behavior in mice through tryptophan-degrading pathway.

Authors:  Ya-Ting Deng; Ming-Gao Zhao; Tian-Jiao Xu; Xin-Hua Li
Journal:  Metab Brain Dis       Date:  2018-06-15       Impact factor: 3.584

Review 3.  Disturbed tryptophan metabolism in cardiovascular disease.

Authors:  H Mangge; I Stelzer; E Z Reininghaus; D Weghuber; T T Postolache; D Fuchs
Journal:  Curr Med Chem       Date:  2014-06       Impact factor: 4.530

4.  Prospective association between adherence to the Mediterranean diet and risk of depressive symptoms in the French SU.VI.MAX cohort.

Authors:  Moufidath Adjibade; Karen E Assmann; Valentina A Andreeva; Cédric Lemogne; Serge Hercberg; Pilar Galan; Emmanuelle Kesse-Guyot
Journal:  Eur J Nutr       Date:  2017-03-10       Impact factor: 5.614

5.  The Association of Major Depressive Disorder with Activation of NLRP3 Inflammasome, Lipid Peroxidation, and Total Antioxidant Capacity.

Authors:  Abdolghader Taene; Ghazaleh Khalili-Tanha; Aliakbar Esmaeili; Leila Mobasheri; Omid Kooshkaki; Somaieh Jafari; Alireza Shokouhifar; Gholamreza Anani Sarab
Journal:  J Mol Neurosci       Date:  2019-09-12       Impact factor: 3.444

6.  Role of inflammatory cytokines in depression: Focus on interleukin-1β.

Authors:  Rai Khalid Farooq; Kashif Asghar; Shahzina Kanwal; Ali Zulqernain
Journal:  Biomed Rep       Date:  2016-11-10

7.  Psychosocial stress as a risk factor for sepsis: a population-based cohort study.

Authors:  Connor Ojard; John P Donnelly; Monika M Safford; Russell Griffin; Henry E Wang
Journal:  Psychosom Med       Date:  2015-01       Impact factor: 4.312

Review 8.  Mechanisms affecting brain remodeling in depression: do all roads lead to impaired fibrinolysis?

Authors:  Silvia Hoirisch-Clapauch
Journal:  Mol Psychiatry       Date:  2021-08-17       Impact factor: 15.992

Review 9.  Neuroimmunomodulation in depression: a review of inflammatory cytokines involved in this process.

Authors:  Helena M Abelaira; Gislaine Z Réus; Fabricia Petronilho; Tatiana Barichello; João Quevedo
Journal:  Neurochem Res       Date:  2014-07-05       Impact factor: 3.996

10.  Mental health symptoms and inflammatory markers among HIV infected patients in Tanzania.

Authors:  Peter Memiah; Lillian Nkinda; Mtebe Majigo; Felix Humwa; Zelalaem Haile; Kennedy Muthoka; Aisha Zuheri; Anne Kamau; Lucy Ochola; Gabriel Buluku
Journal:  BMC Public Health       Date:  2021-06-10       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.